Clinical Trial Search block Test
Phase 1b/2, randomized, double-blind, placebo-controlled, multi-center study of STMC-103H in neonates and infants at high-risk for developing allergic disease
ADORE (STMC-103H-102)
What is the goal of the study?
Primary indication is to see is STMC-103H, prevents allergic disease in at-risk neonates. The primary objective of this study is to assess the safety, tolerability, and preliminary efficacy of STMC-103H compared to placebo in neonate and infant subjects at high risk for development of allergic disease.
Who can participate in the study?
Everyone